Expression of RPS21 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS21 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2311.63

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

1923.8

Number of samples

141

Samples

Sample	Description	TPM
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	5360.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	5247.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	4565.5
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	4381.4
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	4357.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	4263.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	4206.1
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3870.8
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	3736.1
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3581.8
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3502.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	3444.8
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	3400.8
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3307.1
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	3298.9
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	3214.8
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3148.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3011.4
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2877.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2871.6
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2854.5
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2832.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2811.5
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2795.4
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2609.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2606.8
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2589.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2573.8
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2477.6
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	2463.2
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2461.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2363.6
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2352.5
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2324.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2298.6
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2293.8
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	2281.8
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2213.9
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	2169.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2144.2
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2093.5
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2092.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2061.2
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2043.2
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2042.1
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2016.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2001.6
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1983.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1973.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1949.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1940.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1940.1
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1937.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1936.1
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1931.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1924.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1917.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	1908.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1877.6
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1826.3
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1818.2
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1740.8
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1738.9
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1732.9
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1716.1
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1716.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1711.4
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1696.5
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1683.4
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1666.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1660.3
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1654.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1650.8
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1645.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1638.8
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1632.4
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1623.3
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1589.2
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1568.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1563.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1563.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1549.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1540.5
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1516.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1505.0
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1481.4
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1480.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1479.0
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1469.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1468.1
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1468.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1458.4
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1444.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1432.8
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1429.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1428.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1421.4
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1416.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1408.7
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1390.7
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1381.6
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1365.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1364.7
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1359.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1352.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1320.7
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1304.8
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1286.0
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1279.2
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1256.6
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1252.7
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1239.2
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1221.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1188.7
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1186.7
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1159.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1159.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1133.4
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1099.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1099.0
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1096.2
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1075.4
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1049.5
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1031.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1006.8
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1001.6
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	997.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	980.2
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	964.0
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	957.3
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	922.0
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	910.7
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	909.9
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	901.6
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	830.3
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	800.3
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	794.4
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	767.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	757.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	653.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	488.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS21 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 36.26

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

54.3

Number of samples

Samples

Sample	Description	TPM
AK043	N, NA, stage:NA, alive, 660 days	132.2
AK066	N, NA, stage:NA, alive, 960 days	115.3
AK074	N, NA, stage:NA, alive, 300 days	97.1
AK002	N, NA, stage:NA, dead, 570 days	95.7
AK133	N, NA, stage:NA, dead, 360 days	91.8
AK142	N, NA, stage:NA, alive, 90 days	88.4
AK185	N, NA, stage:NA, alive, 330 days	85.0
AK236	N, NA, stage:NA, dead, 360 days	84.7
AK117	N, NA, stage:NA, dead, 210 days	79.5
AK072	N, NA, stage:NA, dead, 150 days	76.4
AK213	N, NA, stage:NA, alive, 2010 days	71.7
AK098	N, NA, stage:NA, dead, 660 days	69.6
AK139	N, NA, stage:NA, dead, 270 days	69.4
AK183	N, NA, stage:NA, alive, 360 days	67.6
AK055	N, NA, stage:NA, dead, 240 days	65.9
AK035	N, NA, stage:NA, dead, 210 days	64.0
AK123	N, NA, stage:NA, dead, 180 days	63.9
AK165	N, NA, stage:NA, alive, 360 days	61.8
AK178	N, NA, stage:NA, dead, 240 days	59.5
AK199	N, NA, stage:NA, alive, 1860 days	58.8
AK195	N, NA, stage:NA, dead, 390 days	57.0
AK124	N, NA, stage:NA, alive, 1920 days	56.5
AK158	N, NA, stage:NA, dead, 360 days	55.2
AK134	N, NA, stage:NA, dead, 360 days	54.3
AK049	N, NA, stage:NA, dead, 180 days	53.6
AK099	N, NA, stage:NA, dead, 420 days	53.4
AK088	N, NA, stage:NA, dead, 360 days	53.4
AK071	N, NA, stage:NA, dead, 540 days	52.2
AK156	N, NA, stage:NA, dead, 330 days	48.8
AK205	N, NA, stage:NA, dead, 120 days	48.7
AK030	N, NA, stage:NA, dead, 120 days	48.0
AK188	N, NA, stage:NA, alive, 420 days	47.8
AK226	N, NA, stage:NA, dead, 360 days	46.4
AK218	N, NA, stage:NA, dead, 180 days	46.1
AK041	N, NA, stage:NA, alive, 810 days	44.3
AK149	N, NA, stage:NA, dead, 420 days	43.8
AK053	N, NA, stage:NA, dead, 300 days	43.1
AK051	N, NA, stage:NA, dead, 360 days	41.7
AK167	N, NA, stage:NA, dead, 180 days	41.6
AK068	N, NA, stage:NA, alive, 360 days	40.8
AK173	N, NA, stage:NA, dead, 180 days	40.3
AK079	N, NA, stage:NA, dead, 210 days	39.5
AK076	N, NA, stage:NA, alive, 660 days	38.1
AK091	N, NA, stage:NA, dead, 210 days	37.5
AK153	N, NA, stage:NA, dead, 240 days	36.8
AK015	N, NA, stage:NA, alive, 720 days	35.7
AK005	N, NA, stage:NA, dead, 240 days	35.6
AK227	N, NA, stage:NA, alive, 300 days	35.3
AK216	N, NA, stage:NA, dead, 360 days	34.7
AK003	N, NA, stage:NA, dead, 600 days	33.7
AK081	N, NA, stage:NA, dead, 180 days	33.0
AK100	N, NA, stage:NA, alive, 960 days	32.4
AK231	N, NA, stage:NA, dead, 240 days	30.6
AK089	N, NA, stage:NA, dead, 330 days	27.6
AK006	N, NA, stage:NA, dead, 360 days	26.8
AK103	N, NA, stage:NA, alive, 1320 days	22.9
AK102	N, NA, stage:NA, alive, 1740 days	19.1
AK085	N, NA, stage:NA, alive, 660 days	18.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0228220003	Tumor	0.6
CPT0093590003	Tumor	0.6
CPT0218690004	Tumor	0.5
CPT0078580003	Tumor	0.5
CPT0224390004	Tumor	0.5
CPT0168080003	Tumor	0.5
CPT0206560003	Tumor	0.5
CPT0205450004	Tumor	0.4
CPT0127480003	Tumor	0.4
CPT0093450003	Tumor	0.4
CPT0161730003	Tumor	0.4
CPT0168830003	Tumor	0.3
CPT0218330004	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0002410011	Tumor	0.3
CPT0218960004	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0167970003	Tumor	0.3
CPT0207090003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0175060003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0206230003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0087680003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0219080004	Tumor	0.2
CPT0217100003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0217710008	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0224540004	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0189570004	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0218890004	Tumor	0.1
CPT0218770003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0071100003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0217190003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0162020003	Tumor	0.0
CPT0205780003	Tumor	0.0
CPT0204360003	Normal	0.0
CPT0224600003	Tumor	0.0
CPT0189460003	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0206330003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0199770003	Tumor	0.0
CPT0189850004	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0186100003	Tumor	-0.1
CPT0206880003	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0218670003	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0189250003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0087570003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0204390003	Normal	-0.1
CPT0208980003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0204350003	Normal	-0.2
CPT0087950003	Tumor	-0.2
CPT0216920008	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0093550003	Tumor	-0.2
CPT0204340003	Normal	-0.2
CPT0064650003	Tumor	-0.2
CPT0204420003	Normal	-0.2
CPT0092440003	Tumor	-0.3
CPT0196850003	Tumor	-0.3
CPT0162140003	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0204330003	Normal	-0.3
CPT0204380003	Normal	-0.4
CPT0204400003	Normal	-0.4
CPT0204410003	Normal	-0.5
CPT0104220003	Tumor	-0.5
CPT0221180003	Tumor	-0.5
CPT0087730003	Tumor	-0.5
CPT0162100003	Tumor	-0.7
CPT0217000004	Tumor	-0.9
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA003371
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, NOS
Glioma, malignant, Low grade